시장보고서
상품코드
1985002

위험 약물 관리 시스템 시장 보고서(2026년)

Hazardous Drug Management Systems Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,736,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,737,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,738,000
카드담기
※ 부가세 별도

유해 약제 관리 시스템 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 13억 8,000만 달러에서 2026년에는 15억 달러로, CAGR 8.9%로 성장할 것으로 전망되고 있습니다. 지난 수년간의 성장 요인으로는 의료진의 안전에 대한 관심 증가, 유해 약물 노출 위험에 대한 인식 개선, 컴플라이언스 중심의 안전 프로토콜 도입 확대, 병원과 약국의 자동화 발전, 산업안전보건 가이드라인 강화 등을 꼽을 수 있습니다.

유해 약제 관리 시스템 시장 규모는 향후 수년간 강력한 성장이 전망되고 있습니다. CAGR 8.6%로 확대하며, 2030년에는 20억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중의 성장은 밀폐형 약물전달 기술의 도입 확대, 유해 약물의 자동 처리에 대한 수요증가, 종양학 분야의 안전 인프라에 대한 투자 증가, 의료시설 전반의 규제 준수 요건 확대, 작업장내 오염 방지에 대한 관심 증가 등에 기인합니다. 예측 기간 중 주요 동향으로는 밀폐형 이송 장비의 기술 주도 혁신, 로봇 및 자동 조제 안전 솔루션의 발전, 실시간 오염 모니터링 시스템 개발, 노출 방지 기술 연구 및 개발 활성화, 통합 유해 약물 추적 및 보고 시스템 혁신 등을 들 수 있습니다. 혁신 등을 들 수 있습니다.

맞춤형 의료의 보급 확대와 점점 더 복잡해지는 정맥주사 프로토콜 증가는 향후 수년간 유해약물 관리 시스템 시장의 성장을 촉진할 것으로 예측됩니다. 맞춤형 의료란 유전적 요인, 바이오마커, 질병 프로파일 등 환자 개개인의 특성에 따라 약물의 선택과 용량을 포함한 의료행위를 최적화하는 것을 말합니다. 맞춤형 의료의 성장은 고도로 맞춤화된 정맥내 조제 및 투여가 필요한 표적 치료법의 승인 및 임상 사용 증가에 의해 촉진되고 있습니다. 유해약물관리시스템은 고효능 및 표적 치료제의 안전한 조제, 취급, 투여를 가능하게 하고, 의료진을 보호하면서 환자별 정확한 치료 제공을 보장함으로써 맞춤형 의료를 지원합니다. 예를 들어 미국 기반의 비영리단체인 'Personalized Medicine Coalition(Personalized Medicine Coalition)에 따르면 2024년 미국 식품의약국(FDA)은 18개의 새로운 맞춤형 의약품을 승인했습니다. 이는 2023년 20건의 승인에 이어 전체 신약 승인 건수의 25% 이상을 차지했으며, 그 중 상당수는 개별화된 정맥주사 제제가 필요했던 것으로 나타났습니다. 그 결과, 맞춤형 의료와 복잡한 투약 프로토콜의 이용 확대가 유해약물 관리 시스템 시장 확대에 기여하고 있습니다.

또한 의약품 임상시험 건수 증가도 향후 유해약물 관리 시스템 시장의 성장을 촉진할 것으로 예측됩니다. 의약품 임상시험은 인간을 대상으로 신약이나 신치료제의 안전성, 유효성, 최적 용량을 평가하기 위해 시행하는 체계적인 연구입니다. 임상시험 활동 증가는 복잡하고 새로운 건강 상태에 대처하기 위한 혁신적인 치료법에 대한 수요증가에 의해 주도되고 있습니다. 위험약물 관리 시스템은 임상시험용 의약품 및 고효능 의약품의 안전하고 정확한 규정 준수를 촉진하여 임상시험을 지원하며, 임상시험 과정 전반에 걸쳐 환자의 안전과 규정 준수를 보장합니다. 예를 들어 2024년 12월 영국에 기반을 둔 단체인 영국제약산업협회(ABPI)에 따르면 영국에서 시작된 제약업계의 임상시험 건수는 2년 연속 증가하여 2022년 411건에서 2023년 426건으로 늘어났다고 합니다. 그 결과, 제약 임상시험 증가가 유해 약물 관리 시스템에 대한 수요를 견인하고 있습니다.

자주 묻는 질문

  • 유해 약제 관리 시스템 시장 규모는 어떻게 변화하고 있나요?
  • 유해 약제 관리 시스템 시장의 성장 요인은 무엇인가요?
  • 맞춤형 의료의 확산이 유해 약제 관리 시스템에 미치는 영향은 무엇인가요?
  • 의약품 임상시험 건수의 증가는 유해 약제 관리 시스템에 어떤 영향을 미치나요?
  • 유해 약제 관리 시스템의 주요 기술 동향은 무엇인가요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.04.13

Hazardous drug management systems are digital and automated solutions designed to support the safe handling, storage, preparation, tracking, and disposal of hazardous medications in regulated environments. Their primary objective is to reduce occupational exposure, prevent medication errors, and maintain compliance with safety and regulatory requirements through controlled and standardized workflows. These systems also enable real-time monitoring, audit preparedness, and risk mitigation across hazardous medication management processes.

The main types of hazardous drug management systems include closed system transfer devices, compounding systems, storage and transport systems, personal protective equipment, and others. Closed system transfer devices prevent hazardous drug vapors and liquids from escaping during handling, reducing exposure risk. Systems can be on-premises, cloud-based, or hybrid. Drug types include antineoplastic, non-antineoplastic hazardous, and reproductive-risk drugs. They support stages from procurement and compounding to administration, disposal, monitoring, and compliance, serving healthcare providers, pharmaceutical firms, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the hazardous drug management systems market by increasing the cost of imported automated compounding devices, closed system transfer devices, and advanced storage solutions. the rise in production and logistics costs has particularly affected regions like north america and europe, where reliance on imported specialized equipment is higher. segments such as drug compounding systems and closed system transfer devices are most affected. however, tariffs have also encouraged local manufacturing and innovation, leading to potential cost optimization and development of region-specific solutions.

The hazardous drug management systems market research report is one of a series of new reports from The Business Research Company that provides hazardous drug management systems market statistics, including hazardous drug management systems industry global market size, regional shares, competitors with a hazardous drug management systems market share, detailed hazardous drug management systems market segments, market trends and opportunities, and any further data you may need to thrive in the hazardous drug management systems industry. This hazardous drug management systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hazardous drug management systems market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.50 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growing focus on healthcare worker safety, increasing awareness of hazardous drug exposure risks, rising adoption of compliance-driven safety protocols, expansion of hospital and pharmacy automation, and growing enforcement of occupational safety guidelines.

The hazardous drug management systems market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing implementation of closed system drug transfer technologies, growing demand for automated hazardous drug handling, rising investment in oncology safety infrastructure, expansion of regulatory compliance requirements across healthcare facilities, and a rise in focus on workplace contamination prevention. Major trends in the forecast period include technology-driven innovations in closed system transfer devices, advancements in robotic and automated compounding safety solutions, developments in real-time contamination monitoring systems, rising research and development in exposure prevention technologies, and innovation in integrated hazardous drug tracking and reporting systems.

The expanding adoption of personalized medicine and increasingly complex infusion protocols is expected to drive the growth of the hazardous drug management systems market in the coming years. Personalized medicine involves tailoring medical treatments, including drug selection and dosing, based on individual patient characteristics such as genetics, biomarkers, and disease profiles. The growth of personalized medicine is fueled by the rising approval and clinical use of targeted therapies that require highly customized intravenous preparation and dosing. Hazardous drug management systems support personalized medicine by enabling the safe preparation, handling, and administration of high-potency and targeted therapies, safeguarding healthcare workers while ensuring accurate, patient-specific treatment delivery. For example, in November 2025, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the US Food and Drug Administration approved 18 new personalized medicines in 2024, representing more than 25% of all new drug approvals, following 20 approvals in 2023, many of which required individualized IV preparation. As a result, the growing use of personalized medicine and complex infusion protocols is contributing to the expansion of the hazardous drug management systems market.

The rising number of pharmaceutical clinical trials is also expected to propel the growth of the hazardous drug management systems market going forward. Pharmaceutical clinical trials are structured research studies conducted to assess the safety, effectiveness, and optimal dosing of new drugs or therapies in human participants. The increase in clinical trial activity is driven by the growing need for innovative treatments to address complex and emerging health conditions. Hazardous drug management systems support clinical trials by facilitating the safe, accurate, and compliant handling of investigational and high-potency drugs, ensuring patient safety and regulatory compliance throughout the trial process. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials initiated in the UK rose for the second consecutive year, increasing from 411 in 2022 to 426 in 2023. Consequently, the growing volume of pharmaceutical clinical trials is driving demand for hazardous drug management systems.

In October 2025, Ideagen PLC, a UK-based provider of software solutions for regulated and high-compliance industries, acquired SafetyStratus Inc. for an undisclosed amount. With this acquisition, Ideagen seeks to strengthen its enterprise environmental, health, and safety (EHS) portfolio by incorporating SafetyStratus's chemical and hazardous management software, thereby expanding its capabilities in hazardous drug and chemical tracking, regulatory compliance, and safety workflows. SafetyStratus Inc. is a US-based company specializing in hazardous drug management systems, offering solutions that support the safe handling, compliance, and tracking of hazardous medications across healthcare and laboratory environments.

Major companies operating in the hazardous drug management systems market are Particle Measuring Systems Inc., Baker Hughes Company, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Esco Healthcare, JMS Co. Ltd., Vygon SA, CODAN Medizinische Gerate GmbH & Co. KG, NuAire Inc., Equashield LLC, Labconco Corporation, Germfree Laboratories Inc., Sentry Air Systems Inc., Simplivia Healthcare Ltd., Mecart Cleanrooms, Corvida Medical Inc.

North America was the largest region in the hazardous drug management systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hazardous drug management systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hazardous drug management systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hazardous drug management systems market consists of revenues earned by entities by providing services such as hazardous drug tracking software, safety compliance management platforms, automated workflow control systems, exposure reporting tools, and inventory monitoring solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The hazardous drug management systems also includes sales of secured storage units, automated dispensing integration systems, barcode tracking hardware, and contamination monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hazardous Drug Management Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hazardous drug management systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hazardous drug management systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hazardous drug management systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Closed System Transfer Devices; Drug Compounding Systems; Drug Storage And Transport Systems; Personal Protective Equipment; Other Product Types
  • 2) By Deployment Mode: On Premises; Cloud Based; Hybrid
  • 3) By Drug Type: Antineoplastic Drugs; Non Antineoplastic Hazardous Drugs; Reproductive Risk Only Drugs
  • 4) By Workflow Stage: Drug Procurement And Storage; Drug Preparation And Compounding; Drug Dispensing And Transportation; Drug Administration; Waste Handling And Disposal; Environmental Monitoring And Decontamination; Personnel Safety And Compliance Management
  • 5) By End User: Healthcare Providers; Pharmaceutical Companies; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Closed System Transfer Devices: Needle Free Connectors; Bag Spike Systems; Luer Lock Adapters; Vial Adapters
  • 2) By Drug Compounding Systems: Automated Compounding Devices; Manual Compounding Devices; Isolator Systems; Compounding Enclosures
  • 3) By Drug Storage And Transport Systems: Refrigerated Storage Units; Temperature Controlled Transport Carts; Lockable Cabinets; Portable Containment Units
  • 4) By Personal Protective Equipment:Gloves; Gowns; Respirators; Eye Protection
  • 5) By Other Product Types: Spill Containment Kits; Decontamination Systems; Waste Disposal Containers; Cleaning Supplies
  • Companies Mentioned: Particle Measuring Systems Inc.; Baker Hughes Company; Becton Dickinson and Company; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; West Pharmaceutical Services Inc.; ICU Medical Inc.; Esco Healthcare; JMS Co. Ltd.; Vygon SA; CODAN Medizinische Gerate GmbH & Co. KG; NuAire Inc.; Equashield LLC; Labconco Corporation; Germfree Laboratories Inc.; Sentry Air Systems Inc.; Simplivia Healthcare Ltd.; Mecart Cleanrooms; Corvida Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hazardous Drug Management Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hazardous Drug Management Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hazardous Drug Management Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hazardous Drug Management Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Real-Time Hazardous Drug Monitoring
    • 4.2.2 Automated Compliance And Audit Systems
    • 4.2.3 Advanced Risk Reduction Protocols
    • 4.2.4 Integrated Safety Workflow Solutions
    • 4.2.5 Smart Inventory And Storage Management

5. Hazardous Drug Management Systems Market Analysis Of End Use Industries

  • 5.1 Healthcare Providers
  • 5.2 Pharmaceutical Companies
  • 5.3 Research Institutes
  • 5.4 Hospitals And Clinics
  • 5.5 Laboratory Facilities

6. Hazardous Drug Management Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hazardous Drug Management Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hazardous Drug Management Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hazardous Drug Management Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hazardous Drug Management Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hazardous Drug Management Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hazardous Drug Management Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hazardous Drug Management Systems Market Segmentation

  • 9.1. Global Hazardous Drug Management Systems Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Closed System Transfer Devices, Drug Compounding Systems, Drug Storage And Transport Systems, Personal Protective Equipment, Other Product Types
  • 9.2. Global Hazardous Drug Management Systems Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • On Premises, Cloud Based, Hybrid
  • 9.3. Global Hazardous Drug Management Systems Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antineoplastic Drugs, Non Antineoplastic Hazardous Drugs, Reproductive Risk Only Drugs
  • 9.4. Global Hazardous Drug Management Systems Market, Segmentation By Workflow Stage, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Procurement And Storage, Drug Preparation And Compounding, Drug Dispensing And Transportation, Drug Administration, Waste Handling And Disposal, Environmental Monitoring And Decontamination, Personnel Safety And Compliance Management
  • 9.5. Global Hazardous Drug Management Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Healthcare Providers, Pharmaceutical Companies, Research Institutes, Other End Users
  • 9.6. Global Hazardous Drug Management Systems Market, Sub-Segmentation Of Closed System Transfer Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Needle Free Connectors, Bag Spike Systems, Luer Lock Adapters, Vial Adapters
  • 9.7. Global Hazardous Drug Management Systems Market, Sub-Segmentation Of Drug Compounding Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Compounding Devices, Manual Compounding Devices, Isolator Systems, Compounding Enclosures
  • 9.8. Global Hazardous Drug Management Systems Market, Sub-Segmentation Of Drug Storage And Transport Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Refrigerated Storage Units, Temperature Controlled Transport Carts, Lockable Cabinets, Portable Containment Units
  • 9.9. Global Hazardous Drug Management Systems Market, Sub-Segmentation Of Personal Protective Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gloves, Gowns, Respirators, Eye Protection
  • 9.10. Global Hazardous Drug Management Systems Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spill Containment Kits, Decontamination Systems, Waste Disposal Containers, Cleaning Supplies

10. Hazardous Drug Management Systems Market Regional And Country Analysis

  • 10.1. Global Hazardous Drug Management Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hazardous Drug Management Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hazardous Drug Management Systems Market

  • 11.1. Asia-Pacific Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hazardous Drug Management Systems Market

  • 12.1. China Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hazardous Drug Management Systems Market

  • 13.1. India Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hazardous Drug Management Systems Market

  • 14.1. Japan Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hazardous Drug Management Systems Market

  • 15.1. Australia Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hazardous Drug Management Systems Market

  • 16.1. Indonesia Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hazardous Drug Management Systems Market

  • 17.1. South Korea Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hazardous Drug Management Systems Market

  • 18.1. Taiwan Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hazardous Drug Management Systems Market

  • 19.1. South East Asia Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hazardous Drug Management Systems Market

  • 20.1. Western Europe Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hazardous Drug Management Systems Market

  • 21.1. UK Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hazardous Drug Management Systems Market

  • 22.1. Germany Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hazardous Drug Management Systems Market

  • 23.1. France Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hazardous Drug Management Systems Market

  • 24.1. Italy Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hazardous Drug Management Systems Market

  • 25.1. Spain Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hazardous Drug Management Systems Market

  • 26.1. Eastern Europe Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hazardous Drug Management Systems Market

  • 27.1. Russia Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hazardous Drug Management Systems Market

  • 28.1. North America Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hazardous Drug Management Systems Market

  • 29.1. USA Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hazardous Drug Management Systems Market

  • 30.1. Canada Hazardous Drug Management Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hazardous Drug Management Systems Market

  • 31.1. South America Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hazardous Drug Management Systems Market

  • 32.1. Brazil Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hazardous Drug Management Systems Market

  • 33.1. Middle East Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hazardous Drug Management Systems Market

  • 34.1. Africa Hazardous Drug Management Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hazardous Drug Management Systems Market, Segmentation By Product Type, Segmentation By Deployment Mode, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hazardous Drug Management Systems Market Regulatory and Investment Landscape

36. Hazardous Drug Management Systems Market Competitive Landscape And Company Profiles

  • 36.1. Hazardous Drug Management Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hazardous Drug Management Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hazardous Drug Management Systems Market Company Profiles
    • 36.3.1. Particle Measuring Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Baker Hughes Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

37. Hazardous Drug Management Systems Market Other Major And Innovative Companies

  • Terumo Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Esco Healthcare, JMS Co. Ltd., Vygon SA, CODAN Medizinische Gerate GmbH & Co. KG, NuAire Inc., Equashield LLC, Labconco Corporation, Germfree Laboratories Inc., Sentry Air Systems Inc., Simplivia Healthcare Ltd., Mecart Cleanrooms, Corvida Medical Inc.

38. Global Hazardous Drug Management Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hazardous Drug Management Systems Market

40. Hazardous Drug Management Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Hazardous Drug Management Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hazardous Drug Management Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hazardous Drug Management Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제